Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction in Diabetic Men.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 14 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Avanafil (Primary)
Indications Erectile dysfunction
Focus Registrational; Therapeutic Use
Acronyms REVIVE-D; REVIVE-Diabetes

Most Recent Events

26 Jun 2013 Avanafil approved for treatment of erectile dysfunction in the EU based on results of the RIVIVE, REVIVE-Diabetes and REVIVE-RP, according to a VIVUS media release.
31 Jul 2012 Results published in the Mayo Clinic Proceedings.
28 Apr 2012 Results from this trial were used to support US FDA approval of avanafil for the treatment of erectile dysfunction.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com